Articles tagged with “life-sciences-ai-consulting”

A 2026 analyst guide to evaluating AI consulting for life sciences: market sizing, FDA/EMA/EU AI Act rules, vendor scorecards, pricing benchmarks, and five named case studies.

A 2026 phased breakdown of the biotech AI strategy timeline, covering 90-day diagnostics, board approval, team building, and 2-3 year scaling, with GSK, Merck, and Moderna case data.

A 2026 methodology guide to running an AI opportunity assessment in biotech: readiness diagnostics, a five-axis use case prioritization matrix, FDA and EU AI Act context, and five named case studies.

A 2026 framework for biotech AI strategy: a five-axis prioritization matrix, FDA/EMA risk tiering, data readiness benchmarks, ROI data, and five named case studies including Insilico, Recursion, and Xaira.